Virginia Commonwealth University
Medicines are meant for everyone.
The Medicines for All institute (M4ALL) at Virginia Commonwealth University’s College of Engineering is dramatically improving global access to lifesaving medicines. Our innovative approach to synthesizing drugs and manufacturing pharmaceuticals is enhancing production worldwide by reducing costs and waste.
- $70 million from The Bill & Melinda Gates Foundation, USG and other donors.
- 22 drugs improved for COVID-19, HIV, TB and malaria.
Leading the world in pharmaceutical manufacturing.
From simplifying raw materials to introducing revolutionary new production methods, VCU and Medicines for All are reimagining every step of the pharmaceutical manufacturing process. Here are some of the ways we’re changing the game:
Optimizing operations
We redesign processes to empower more cost-effective and sustainable pharmaceutical manufacturing. Read more
Securing supply chains
We’re bringing essential medicine production back to the United States, reducing dependence on offshore production. Read more
Top chemists and engineers
We train scientists to use creativity in chemistry, with advanced techniques and state-of-the-art facilities. Read more
Driving down costs of care
We remove barriers to producing essential medicines that combat diseases such as COVID-19. Read more
- 90% HIV/AIDS patients will use treatments developed by M4ALL.
- COVID-19 drugs across the globe are being developed with processes from M4ALL.
A new era in global health equity.
At Medicines for All, we’re constantly seeking big ideas and innovations. By engaging with us early on in clinical development, researchers make the same drugs affordable and available to everyone in the world at the same time. Because everyone deserves access to life-changing opportunities.
Connect with M4ALL and start making an impact in global health.